COHERUS BIOSCIENCES I

NetDania - New 12 months Low: COHERUS BIOSCIENCES INC. - COMMON STOCK

05 авг 2024 09:45:04 Источник NetDania Notify

Coherus to Report Second Quarter 2024 Financial Results on August 8, 2024

01 авг 2024 09:00:00 Источник Nasdaq GlobeNewswire

NetDania - New 12 months Low: COHERUS BIOSCIENCES INC. - COMMON STOCK

08 июл 2024 09:58:08 Источник NetDania Notify

NetDania - New 12 months Low: COHERUS BIOSCIENCES INC. - COMMON STOCK

05 июл 2024 09:50:52 Источник NetDania Notify

NetDania - New 12 months Low: COHERUS BIOSCIENCES INC. - COMMON STOCK

03 июл 2024 09:46:52 Источник NetDania Notify

NetDania - New 12 months Low: COHERUS BIOSCIENCES INC. - COMMON STOCK

02 июл 2024 11:28:48 Источник NetDania Notify

Coherus BioSciences Announces Divestiture of YUSIMRY (adalimumab-aqvh) in a $40 Million Upfront All Cash Transaction

27 июн 2024 08:26:59 Источник Nasdaq GlobeNewswire

Coherus BioSciences Appoints Rita Karachun, CPA, CGMA to its Board of Directors

05 июн 2024 09:00:00 Источник Nasdaq GlobeNewswire

Coherus Management to Present at the 2024 Jefferies Global Healthcare Conference

30 май 2024 09:00:00 Источник Nasdaq GlobeNewswire

Coherus Presents Preliminary Results from Phase I Dose Escalation Study of its Anti-chemokine receptor 8 (CCR8) Antibody, CHS-114, at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

23 май 2024 17:51:06 Источник Nasdaq GlobeNewswire

Coherus Management to Present at the TD Cowen 5th Annual Oncology Innovation Virtual Summit: Insights for ASCO & EHA

23 май 2024 09:00:00 Источник Nasdaq GlobeNewswire

Coherus BioSciences Reports First Quarter 2024 Financial Results and Provides Business Update

09 май 2024 16:01:00 Источник Nasdaq GlobeNewswire

Coherus Announces Full Repayment of Pharmakon Advisors $75 Million Term Loan

09 май 2024 07:30:00 Источник Nasdaq GlobeNewswire

Coherus Announces Clinical Collaboration with the Cancer Research Institute for a Novel Combination Evaluating LOQTORZI® (toripalimab-tpzi) with ENB Therapeutics' ENB-003 for the Treatment of Ovarian Cancer

08 май 2024 09:00:00 Источник Nasdaq GlobeNewswire

Coherus to Report First Quarter 2024 Financial Results on May 9, 2024

01 май 2024 16:30:00 Источник Nasdaq GlobeNewswire

Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

24 апр 2024 10:02:18 Источник Nasdaq GlobeNewswire

Coherus Presents Preclinical Data for CHS-1000, a Novel Anti-ILT4 Antibody, at the 2024 AACR Annual Meeting

08 апр 2024 08:30:00 Источник Nasdaq GlobeNewswire

Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update

13 мар 2024 16:01:00 Источник Nasdaq GlobeNewswire

Coherus to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024

05 мар 2024 16:01:00 Источник Nasdaq GlobeNewswire

Coherus Completes Divestiture of Ophthalmology Franchise

04 мар 2024 01:00:00 Источник Nasdaq GlobeNewswire